These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9093880)

  • 1. Variations of serum IgG subclass levels in hepatitis C virus infection during interferon-alpha therapy.
    Musset L; Ghillani P; Lunel F; Cacoub P; Cresta P; Frangeul L; Rosenheim M; Preud'homme JL
    Immunol Lett; 1997 Jan; 55(1):41-5. PubMed ID: 9093880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
    Nagayama R; Miyake K; Tsuda F; Okamoto H
    J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting treatment responses to interferon-alpha in chronic hepatitis C.
    Pawlotsky JM; Roudot-Thoraval F; Bastie A; Darthuy F; Rémiré J; Métreau JM; Zafrani ES; Duval J; Dhumeaux D
    J Infect Dis; 1996 Jul; 174(1):1-7. PubMed ID: 8655978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of IgG and IgM HCV antibody secretion in vitro in patients with chronic hepatitis C: correlation with disease activity and response to interferon-alpha.
    Löhr H; Nagel C; Dienes HP; Simpson B; Michel G; Goergen B; Meyer zum Büschenfelde KH; Gerken G
    Hepatology; 1994 Dec; 20(6):1383-9. PubMed ID: 7526999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.
    Douglas DD; Rakela J; Lin HJ; Hollinger FB; Taswell HF; Czaja AJ; Gross JB; Anderson ML; Parent K; Fleming CR
    Dig Dis Sci; 1993 Apr; 38(4):601-7. PubMed ID: 8384978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C.
    Aiyama T; Yoshioka K; Hirofuji H; Kusakabe A; Yamada M; Tanaka K; Kakumu S
    Dig Dis Sci; 1994 Oct; 39(10):2244-9. PubMed ID: 7924750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and antibody profiles of chronic hepatitis C patients: relation to hepatitis C virus genotypes.
    Yuki N; Hayashi N; Mita E; Hagiwara H; Oshita M; Ohkawa K; Katayama K; Kasahara A; Fusamoto H; Kamada T
    J Med Virol; 1995 Feb; 45(2):162-7. PubMed ID: 7539828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alpha.
    Morishima I; Kumada T; Nakano S; Takeda I; Sugiyama K; Osada T; Kiriyama S; Ohki H; Suga T; Ito O
    Scand J Gastroenterol; 1995 Aug; 30(8):807-11. PubMed ID: 7481551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(5):319-24. PubMed ID: 8588128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate interferon-alpha therapy for chronic hepatitis C: an assessment by quantitative changes in serum hepatitis C virus-RNA.
    Watanabe S; Kobayashi Y; Konishi M; Yokoi M; Kakehashi R; Kaito M; Suzuki S
    Intern Med; 1993 Jul; 32(7):523-9. PubMed ID: 8286827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha.
    Löhr HF; Elste C; Dienes HP; Michel G; Braun HB; Meyer zum Büschenfelde KH; Gerken G
    J Hepatol; 1996 Sep; 25(3):292-300. PubMed ID: 8895007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates.
    Hartmann H; Schott P; Polzien F; Mihm S; Uy A; Kaboth U; Pardowitz I; Ramadori G
    Z Gastroenterol; 1995 Nov; 33(11):643-50. PubMed ID: 8600660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-hepatitis C virus immunoglobulin M antibody in patients with chronic hepatitis type C.
    Kikuchi T; Onji M; Michitaka K; Ohta Y
    Hepatogastroenterology; 1992 Dec; 39(6):525-8. PubMed ID: 1336473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C.
    Quiroga JA; Herrero M; Castillo I; Navas S; Pardo M; Carreño V
    J Infect Dis; 1994 Sep; 170(3):669-73. PubMed ID: 7521377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum.
    Ampurdanés S; Olmedo E; Maluenda MD; Forns X; López-Labrador FX; Costa J; Sánchez-Tapias JM; de Anta MT; Rodés J
    J Hepatol; 1996 Dec; 25(6):827-32. PubMed ID: 9007709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa.
    Tanaka E; Kiyosawa K; Matsumoto A; Kashiwakuma T; Hasegawa A; Mori H; Yanagihara O; Ohta Y
    Hepatology; 1996 Jun; 23(6):1330-3. PubMed ID: 8675147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
    Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; Carreño V
    Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia.
    Polzien F; Schott P; Mihm S; Ramadori G; Hartmann H
    J Hepatol; 1997 Jul; 27(1):63-71. PubMed ID: 9252075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.